| Date Filed | Type | Description |
| 08/24/2023 |
4
| Collard Craig A (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 692 shares
@ $1.65, valued at
$1.1k
|
|
| 05/24/2023 |
4
| Collard Craig A (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 691 shares
@ $1.45, valued at
$1k
|
|
| 04/05/2023 |
4
| Collard Craig A (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 3,000,000 options to buy
@ $1.78, valued at
$5.3M
Granted 250,000 restricted stock units
@ $0
Granted 4,250,000 options to buy
@ $1.78, valued at
$7.6M
|
|
| 03/03/2023 |
4
| Collard Craig A (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 53,822 shares
@ $20, valued at
$1.1M
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 5,000 options to buy
@ $17.61, valued at
$88.1k
Disposed/sold 2,500 options to buy
@ $12.75, valued at
$31.9k
Disposed/sold 2,500 options to buy
@ $8.79, valued at
$22k
Disposed/sold 2,500 options to buy
@ $13.3, valued at
$33.3k
|
|
| 03/02/2023 |
3
| Collard Craig A (Director) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/ |
| 09/27/2022 |
4
| Collard Craig A (Director) has filed a Form 4 on TerrAscend Corp.|
Txns:
| Bought 60,000 shares
@ $0 |
|
| 09/26/2022 |
4
| Collard Craig A (Director) has filed a Form 4 on TerrAscend Corp.|
Txns:
| Bought 120,000 shares
@ $0 |
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2022 |
4
| Collard Craig A (Director) has filed a Form 4 on TerrAscend Corp.|
Txns:
| Exercised (in-or-at-the-money) 52,939 warrants
@ $2.54, valued at
$134.5k
|
|
| 01/03/2022 |
3
| Collard Craig A (Director) has filed a Form 3 on TerrAscend Corp. |
| 11/24/2021 |
4
| Collard Craig A (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Bought 5,601 shares
@ $22.945, valued at
$128.5k
Bought 7,899 shares
@ $23.085, valued at
$182.3k
|
|
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Collard Craig A (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 2,000 shares
@ $0
Granted 2,500 options to buy
@ $8.79, valued at
$22k
|
|
| 05/29/2020 |
4
| Collard Craig A (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 10,000 options to buy
@ $13.88, valued at
$138.8k
|
|
| 05/29/2020 |
3
| Collard Craig A (Director) has filed a Form 3 on Sierra Oncology, Inc. |
| 06/13/2019 |
4
| Collard Craig A (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 options to buy
@ $12.75, valued at
$31.9k
|
|
| 10/31/2018 |
4
| Collard Craig A (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 5,000 options to buy
@ $17.61, valued at
$88.1k
|
|
| 10/31/2018 |
3
| Collard Craig A (Director) has filed a Form 3 on OPIANT PHARMACEUTICALS, INC. |
| 02/04/2014 |
4
| Collard Craig A (CEO) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC|
Txns:
| Disposed/sold 1,567,225 shares
@ $9.5, valued at
$14.9M
Disposed/sold 45,000 shares
@ $9.5, valued at
$427.5k
Disposed/sold 11,904 options to buy
@ $0.43, valued at
$5.1k
Disposed/sold 238,083 options to buy
@ $1.77, valued at
$421.4k
Disposed/sold 35,712 options to buy
@ $3.9, valued at
$139.3k
Disposed/sold 50,000 options to buy
@ $7.09, valued at
$354.5k
Disposed/sold 200,000 options to buy
@ $5.26, valued at
$1.1M
Disposed/sold 95,000 options to buy
@ $5.25, valued at
$498.8k
Disposed/sold 95,000 options to buy
@ $5.74, valued at
$545.3k
|
|
| 03/07/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2012 |
4
| Collard Craig A (CEO) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC|
Txns:
| Granted 95,000 options to buy
@ $5.74, valued at
$545.3k
|
|
| 04/03/2012 |
4
| Collard Craig A (CEO) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC|
Txns:
| Sold 1,443,913 shares
@ $6.25, valued at
$9M
|
|
| 12/20/2010 |
4
| Collard Craig A (President and CEO) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC|
Txns:
| Sold 385,000 shares
@ $6.02, valued at
$2.3M
|
|
| 03/09/2010 |
4
| Collard Craig A (President and CEO) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC|
Txns:
| Granted 200,000 options to buy
@ $5.26, valued at
$1.1M
|
|
| 07/30/2009 |
4
| Collard Craig A (President and CEO) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 06/01/2009 |
4
| Collard Craig A (President and CEO) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |